Trend analysis of ACSC bed days in Irish acute public hospitals 2011–2016
| ACSC | Absolute change in bed days | % change in standardised bed day rate | Incidence rate ratio for trend | 95% CI |
| Vaccine preventable | ||||
| Total | 62 395 | 8.2 | 1.02*** | 1.017 to 1.027 |
| Influenza and pneumonia | 62 700 | 8.2 | 1.02*** | 1.018 to 1.027 |
| Other vaccine preventable | −305 | −25.4 | 0.90* | 0.791 to 1.014 |
| Acute | ||||
| Total | 56 773 | 19.7 | 1.03*** | 1.028 to 1.040 |
| Pyelonephritis | 46 554 | 46.5 | 1.07*** | 1.064 to 1.083 |
| Cellulitis | 13 284 | 21.5 | 1.05*** | 1.035 to 1.063 |
| Convulsions and epilepsy | 3829 | 5.1 | 1.01 | 0.9905 to 1.023 |
| Dehydration and Gastro Intestinal Infection | −4,405 | −44.9 | 0.94*** | 0.913 to 0.967 |
| Dental | 393 | 3.7 | 1.00 | 0.963 to 1.036 |
| Ear Nose & Throat infections | 250 | 5.5 | 1.00 | 0.973 to 1.029 |
| Gangrene | −538 | −22.1 | 0.98 | 0.955 to 1.010 |
| Perforated ulcer | −2,280 | −38.2 | 0.93*** | 0.898 to 0.967 |
| Pelvic Inflammatory Disease | −314 | −22.5 | 0.96 | 0.893 to 1.038 |
| Chronic | ||||
| Total | −7,442 | −10.7 | 0.97*** | 0.969 to 0.979 |
| COPD | 18 107 | 1.1 | 1.16*** | 1.157 to 1.171 |
| Congestive Heart Failure | −1,201 | −11.4 | 0.97*** | 0.961 to 0.980 |
| Diabetic complications | −11,444 | −34.1 | 0.91*** | 0.902 to 0.924 |
| Angina | −8,163 | −43.8 | 0.90*** | 0.885 to 0.9195 |
| Asthma | 2877 | 17.6 | 1.03** | 1.007 to 1.063 |
| Hypertension | 774 | 3.0 | 1.01 | 0.967 to 1.047 |
| Iron deficiency anaemia | 3916 | 40.5 | 1.05*** | 1.026 to 1.083 |
| Nutritional deficiencies | 174 | 633.7 | 1.08 | 0.838 to 1.380 |
| ACSC contribution to public bed days | 111 726 | 18.2 | 1.03*** | 1.033 to 1.034 |
* p<0.1; **P<0.05; ***p<0.01
ACSC, ambulatory care sensitive condition; COPD, chronic obstructive pulmonary disease.